179 related articles for article (PubMed ID: 11856117)
1. Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization.
Wolter H; Gottfried HW; Mattfeldt T
BJU Int; 2002 Feb; 89(3):310-6. PubMed ID: 11856117
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization.
Wolter H; Trijic D; Gottfried HW; Mattfeldt T
Eur Urol; 2002 Mar; 41(3):328-34. PubMed ID: 12180237
[TBL] [Abstract][Full Text] [Related]
3. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal changes during development and progression of prostate adenocarcinomas.
Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
[TBL] [Abstract][Full Text] [Related]
5. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
6. Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization.
Kasahara K; Taguchi T; Yamasaki I; Kamada M; Shuin T
Cancer Genet Cytogenet; 2005 May; 159(1):84-8. PubMed ID: 15860364
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
Alers JC; Krijtenburg PJ; Vis AN; Hoedemaeker RF; Wildhagen MF; Hop WC; van Der Kwast TT; Schröder FH; Tanke HJ; van Dekken H
Am J Pathol; 2001 Feb; 158(2):399-406. PubMed ID: 11159178
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer.
Sattler HP; Rohde V; Bonkhoff H; Zwergel T; Wullich B
Prostate; 1999 May; 39(2):79-86. PubMed ID: 10221562
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal basis of adenocarcinoma of the prostate.
Verma RS; Manikal M; Conte RA; Godec CJ
Cancer Invest; 1999; 17(6):441-7. PubMed ID: 10434955
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization.
El Gedaily A; Bubendorf L; Willi N; Fu W; Richter J; Moch H; Mihatsch MJ; Sauter G; Gasser TC
Prostate; 2001 Feb; 46(3):184-90. PubMed ID: 11170146
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
Chu LW; Troncoso P; Johnston DA; Liang JC
Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetics of prostate cancer.
Nupponen NN; Visakorpi T
Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
14. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.
Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH
Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM; Clausen OP; Schjølberg A; Stokke T
Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
[TBL] [Abstract][Full Text] [Related]
18. Identification of genetic markers for prostatic cancer progression.
Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal imbalances in wood dust-related adenocarcinomas of the inner nose and their associations with pathological parameters.
Korinth D; Pacyna-Gengelbach M; Deutschmann N; Hattenberger S; Bockmühl U; Dietel M; Schroeder HG; Donhuijsen K; Petersen I
J Pathol; 2005 Oct; 207(2):207-15. PubMed ID: 16041693
[TBL] [Abstract][Full Text] [Related]
20. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
